Western Carolina Retinal Associates
Welcome,         Profile    Billing    Logout  
 5 Trials 
18 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Eichenbaum, David
DETeR, NCT04563299: Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections

Terminated
4
10
US
Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate
Retina Vitreous Associates of Florida, Ocular Therapeutix, Inc.
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion
02/23
02/23
ARCHER II, NCT06510816: A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA)

Recruiting
3
630
US
ANX007, Sham Administration
Annexon, Inc.
Geographic Atrophy
10/26
10/27
GION, NCT06178055: A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO)

Active, not recruiting
2
75
US
KUS121 high dose, KUS121 low dose, Sham procedure
Kyoto Drug Discovery and Development Co., Ltd.
Central Retinal Artery Occlusion
03/25
12/25
SIGLEC, NCT05839041: A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Active, not recruiting
2
300
US
AVD-104, Avacincaptad
Aviceda Therapeutics, Inc.
Geographic Atrophy of the Macula, Macular Degeneration
09/25
09/26
NCT06116916: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Recruiting
2
150
Japan, US, RoW
KHK4951, Aflibercept Injection
Kyowa Kirin Co., Ltd.
Diabetic Macular Edema (DME)
11/25
12/25
NCT06116890: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Recruiting
2
180
Japan, US, RoW
KHK4951, Aflibercept Injection
Kyowa Kirin Co., Ltd.
Neovascular Age-Related Macular Degeneration (nAMD)
11/25
12/25
NCT05230537: A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Recruiting
2
146
Europe, US, RoW
Iptacopan (LNP023), Placebo
Novartis Pharmaceuticals
Age-Related Macular Degeneration
10/26
10/26
NCT05930561: 4D-150 in Patients With Diabetic Macular Edema

Recruiting
2
72
US
4D-150 IVT, Aflibercept IVT, Eylea
4D Molecular Therapeutics
Diabetic Macular Edema, Diabetic Retinopathy
02/28
07/28
PRISM, NCT05197270: 4D-150 in Patients with Neovascular (Wet) Age-Related Macular Degeneration

Recruiting
1/2
215
US
4D-150 IVT, Aflibercept IVT
4D Molecular Therapeutics
Neovascular (Wet) Age-Related Macular Degeneration
11/25
11/26
Stone, Cameron M
NCT05930561: 4D-150 in Patients With Diabetic Macular Edema

Recruiting
2
72
US
4D-150 IVT, Aflibercept IVT, Eylea
4D Molecular Therapeutics
Diabetic Macular Edema, Diabetic Retinopathy
02/28
07/28
PRISM, NCT05197270: 4D-150 in Patients with Neovascular (Wet) Age-Related Macular Degeneration

Recruiting
1/2
215
US
4D-150 IVT, Aflibercept IVT
4D Molecular Therapeutics
Neovascular (Wet) Age-Related Macular Degeneration
11/25
11/26
Bridges, William
ARCHER II, NCT06510816: A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA)

Recruiting
3
630
US
ANX007, Sham Administration
Annexon, Inc.
Geographic Atrophy
10/26
10/27
NCT04740671 / 2020-005364-57: A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

Completed
3
410
Europe, US, RoW
HLX04-O, ranibizumab
Shanghai Henlius Biotech
Age Related Macular Degeneration
12/24
12/24
Flores, Flor
SAFE KIDNEY II, NCT05769582: Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients

Recruiting
2/3
180
US
Anti-BK polyomavirus (AntiBKV)
Memo Therapeutics AG
BK Viremia; BKV DNAemia
11/24
11/24
CONCERTO, NCT05438732: Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

Recruiting
N/A
125
US
smaller incision, new generation implantable miniature telescope (SING-IMT)
VisionCare, Inc., ORA, Inc.
Age-Related Macular Degeneration, Geographic Atrophy
12/25
12/25
NCT05074160: OCS Liver Perfusion (OLP) Post-Approval Registry

Active, not recruiting
N/A
166
US
OCS Liver
TransMedics
Liver Transplant
06/25
06/26
Watkins, Vera
PRISM, NCT05197270: 4D-150 in Patients with Neovascular (Wet) Age-Related Macular Degeneration

Recruiting
1/2
215
US
4D-150 IVT, Aflibercept IVT
4D Molecular Therapeutics
Neovascular (Wet) Age-Related Macular Degeneration
11/25
11/26
Hall, McCayla
PRISM, NCT05197270: 4D-150 in Patients with Neovascular (Wet) Age-Related Macular Degeneration

Recruiting
1/2
215
US
4D-150 IVT, Aflibercept IVT
4D Molecular Therapeutics
Neovascular (Wet) Age-Related Macular Degeneration
11/25
11/26

Download Options